4.3 Article

Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT)

Journal

STRAHLENTHERAPIE UND ONKOLOGIE
Volume 192, Issue 11, Pages 815-819

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00066-016-1008-6

Keywords

Radiosurgery; Adaptive fractionated stereotactic radiotherapy; Benign meningioma; Gamma Knife; Patient tracking

Funding

  1. Department of Radiation Oncology, University Medical Center Mannheim
  2. Elekta AB, Stockholm, Sweden
  3. Elekta AB
  4. Zeiss AG

Ask authors/readers for more resources

Objective The Gamma Knife Icon (Elekta AB, Stockholm, Sweden) allows frameless stereotactic treatment using a combination of cone beam computer tomography (CBCT), a thermoplastic mask system, and an infrared-based high-definition motion management (HDMM) camera system for patient tracking during treatment. We report on the first patient with meningioma at the left petrous bone treated with adaptive fractionated stereotactic radiotherapy (a-gkFSRT). Methods The first patient treated with Gamma Knife Icon at our institute receivedMR imaging for preplanning before treatment. For each treatment fraction, a daily CBCT was performed to verify the actual scull/tumor position. The system automatically adapted the planned shot positions to the daily position and recalculated the dose distribution (online adaptive planning). During treatment, the HDMM system recorded the intrafractional patient motion. Furthermore, the required times were recorded to define a clinical treatment slot. Results Total treatment time was around 20 min. Patient positioning needed 0.8 min, CBCT positioning plus acquisition 1.65 min, CT data processing and adaptive planning 2.66 min, and treatment 15.6 min. The differences for the five daily CBCTs compared to the reference are for rotation: -0.59 +/- 0.49 degrees/0.18 +/- 0.20 degrees/0.05 +/- 0.36 degrees and for translation: 0.94 +/- 0.52 mm/-0.08 +/- 0.08 mm/-1.13 +/- 0.89 mm. Over all fractions, an intrafractional movement of 0.13 +/- 0.04 mm was observed. Conclusion The Gamma Knife Icon allows combining the accuracy of the stereotactic Gamma Knife system with the flexibility of fractionated treatment with the mask system and CBCT. Furthermore, the Icon system introduces a new online patient tracking system to the clinical routine. The interfractional accuracy of patient positioning was controlled with a thermoplastic mask and CBCT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper

Olga Golubnitschaja, Peter Kubatka, Alena Mazurakova, Marek Samec, Abdullah Alajati, Frank A. Giordano, Vincenzo Costigliola, Joerg Ellinger, Manuel Ritter

Summary: Prostate cancer is a multifactorial disease with increasing global incidence and rapidly rising treatment costs. Specific blood profiles play a crucial role in risk assessment, disease prevention, and personalized treatment, presenting a new paradigm in PCa management.

CANCERS (2022)

Review Oncology

Targeting Cell Cycle Checkpoint Kinases to Overcome Intrinsic Radioresistance in Brain Tumor Cells

Tijana Vlatkovic, Marlon R. Veldwijk, Frank A. Giordano, Carsten Herskind

Summary: This review summarizes the knowledge in brain tumor treatment through radiosensitization and cell cycle checkpoint inhibition via targeting ATM, ATR, CHK1, CHK2, and WEE1 kinases. Radiation therapy is an important part of standard treatment for brain tumors, but tumor cells' resistance limits its efficacy. Inhibiting cell cycle checkpoint control to increase tumor sensitivity to radiation therapy is a promising approach.

CANCERS (2022)

Article Otorhinolaryngology

Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer

Muemtaz Koeksal, Leonard Saur, Davide Scafa, Gustavo Sarria, Christina Leitzen, Christopher Schmeel, Frederick Far, Sebastian Strieth, Frank A. Giordano

Summary: This study identified factors associated with decision regret among head and neck cancer patients who underwent surgery and adjuvant radiotherapy. Higher decision regret scores were linked to lower single fraction dose, more restriction in everyday life, and various post-treatment symptoms such as trouble speaking and swallowing. Recommendations include psychosocial support for patients undergoing adjuvant radiation and considering hypofractionation for lower decision regret.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Oncology

Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation-induced profibrotic fibroblast responses

Chun-Shan Liu, Inmaculada Rioja, Ali Bakr, Marlon R. Veldwijk, Elena Sperk, Carsten Herskind, Dieter Weichenhan, Rab K. Prinjha, Christoph Plass, Peter Schmezer, Odilia Popanda

Summary: This study investigated the effects and toxicity of different inhibitors targeting BET proteins on radiation-induced fibroblast activation. The results showed that BD2-selective targeting inhibitors efficiently suppressed the expression of DGKA and profibrotic markers without showing cytotoxicity.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Oncology

Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?

Christian Moehring, Aliki Timotheou, Adrianna Manczak, Farsaneh Sadeghlar, Taotao Zhou, Robert Mahn, Alexandra Bartels, Malte Monin, Marieta Toma, Georg Feldmann, Peter Brossart, Muemtaz Koeksal, Gustavo R. Sarria, Frank A. Giordano, Philipp Lingohr, Azin Jafari, Joerg C. Kalff, Christian P. Strassburg, Maria A. Gonzalez-Carmona

Summary: This study analyzed the real-life experience of elderly patients with advanced or metastatic GC or AEG treated with FLOT as first-line palliative chemotherapy. The ECOG performance status showed a stronger prognostic value than patient age in this cohort.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Oncology

Low rate of function-limiting side effects with high-dose adjuvant radiotherapy in high-grade soft tissue extremity sarcomas: a retrospective single-center analysis over 10 years

Muemtaz Koeksal, Maike van der Hoek, Davide Scafa, David Koch, Christina Leitzen, Leonard C. Schmeel, Georg Feldmann, Andreas Strauss, Sebastian Koob, Frank A. Giordano

Summary: In this study, the researchers investigated the effects of adjuvant radiotherapy on patients with extremity soft-tissue sarcomas and analyzed the side effects of radiotherapy as well as predictive factors for patient prognosis. The results showed that radiotherapy was beneficial for improving local control, especially for high-grade sarcomas. Although radiotherapy caused some side effects, the occurrence rate of severe long-term function-limiting adverse events was low.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Review Oncology

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Siyao Deng, Tijana Vlatkovic, Moying Li, Tianzuo Zhan, Marlon R. Veldwijk, Carsten Herskind

Summary: This review focuses on the role of DNA damage response and repair pathways in radiotherapy, and the potential for enhancing the sensitivity of colorectal cancer to radiotherapy by targeting cell-cycle checkpoint proteins.

CANCERS (2022)

Article Oncology

Impact of patient nationality on the severity of early side effects after radiotherapy

Mumtaz Koeksal, Romy Streppel, Stefan Hauser, Alina Abramian, Christina Kaiser, Maria Gonzalez-Carmona, Georg Feldmann, Niklas Schaefer, Sebastian Koob, Mohammed Banat, Motaz Hamed, Frank A. Giordano, Leonard C. Schmeel

Summary: This study investigated whether the severity of early side effects after radiotherapy are associated with patient nationality and other sociodemographic and clinical characteristics. The results showed that non-German patients were more likely to have severe side effects, and side effect severity was also associated with tumor entity, concomitant therapy, body mass index, and age. These findings suggest a need to develop targeted preventive measures for foreign cancer patients and further research on predicting factors for radiotherapy side effects, including other sociodemographic characteristics, to better personalize therapy regimens.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Oncology

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial

J. Weller, N. Schaefer, C. Schaub, T. Tzaridis, T. Zeyen, M. Schneider, A. L. Potthoff, F. A. Giordano, J. P. Steinbach, P. S. Zeiner, T. Kowalski, M. Sabel, P. Hau, D. Krex, O. Grauer, R. Goldbrunner, O. Schnell, G. Tabatabai, F. Ringel, F. Schmidt-Graf, S. Brehmer, J. C. Tonn, L. Bullinger, P. Vajkoczy, M. Glas, H. Vatter, U. Herrlinger, C. Seidel

Summary: In the CeTeG/NOA-09 randomized phase III trial, TMZ/CCNU combination therapy was found to be superior to TMZ in newly diagnosed MGMT methylated glioblastoma, with higher incidence of hematotoxicity. This study analyzed high-grade hematotoxicity and its prognostic relevance in the trial population.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Oncology

Peripheral blood kinetics following total body irradiation and allogeneic hematopoietic stem cell transplantation: Timing matters

Cas S. Dejonckheere, Alexander M. C. Boehner, Eva Schmitz, Tobias A. W. Holderried, Leonard C. Schmeel, Peter Brossart, Frank A. Giordano, Mumtaz A. Koeksal

Summary: A retrospective analysis of 48 adult patients showed that a longer interval of >= 3 days between TBI completion and allo-HSCT was associated with improved overall survival and better peripheral blood kinetics after successful engraftment, suggesting the importance of timing in improving patient outcomes.

CANCER MEDICINE (2023)

Article Oncology

Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial

Douglas Guedes de Castro, Paulo Issamu Sanematsu Junior, Antonio Cassio Assis Pellizzon, Sergio Hideki Suzuki, Ricardo Cesar Fogaroli, Jose Eduardo Souza Dias Junior, Guilherme Rocha Melo Gondim, Daniel Alvarez Estrada, Maria Leticia Gobo Silva, Marcio Saquy Rassi, Michael Jenwei Chen, Richard Giacomelli, Henderson Ramos, Elson Santos Neto, Carolina Humeres Abrahao, Tharcisio Machado Coelho, Liao Shin Yu, Cassio de Queiroz Tannous, Vinicius Fernando Calsavara, Frank Anton Giordano, Jean Goncalves de Oliveira

Summary: Objective: To evaluate the effect of intraoperative radiotherapy (IORT) on local control (LC) and brain disease control (BDC) after resection of brain metastases (BM). Conclusion: IORT for completely resected BM is associated with a potential high local control and low risk of radiation necrosis (RN), warranting further studies.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Oncology

Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer

Lea Hoppen, Gustavo R. Sarria, Chung S. Kwok, Judit Boda-Heggemann, Daniel Buergy, Michael Ehmann, Frank A. Giordano, Jens Fleckenstein

Summary: This study evaluated the impact of daily online adaptive radiation therapy (ART) strategies on dose-volume metrics in patients with lung cancer. The results showed that ART can reduce lung doses while maintaining good target coverage or escalate target doses without increasing ipsilateral lung exposure. The clinical benefits of these strategies should be further evaluated in prospective clinical trials.

RADIATION ONCOLOGY (2023)

Review Oncology

Mobile applications in radiation oncology-current choices and future potentials

Stefan Janssen, Rami A. El Shafie, Arne M. Ruder, Daniel Buergy, Davide Scafa, Frank A. Giordano, Nils H. Nicolay, Marco M. E. Vogel, Stephanie E. Combs, Fabian B. Fahlbusch, Dirk Rades, Lukas Kaesmann

Summary: This article reviews the existing scientific literature on mobile applications in the field of radiation oncology and evaluates the characteristics of commercially available apps across different platforms. A systematic review of the literature and searches in major app marketplaces were conducted. The findings show that there is a limited availability of radiation oncology apps for patients and healthcare professionals in common marketplaces, with most apps focusing on supporting healthcare professionals.

STRAHLENTHERAPIE UND ONKOLOGIE (2023)

Article Oncology

Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective Analysis

Julian P. Layer, Katharina Layer, Gustavo R. Sarria, Fred Roehner, Cas S. Dejonckheere, Lea L. Friker, Thomas Zeyen, David Koch, Davide Scafa, Christina Leitzen, Muemtaz Koeksal, Frederic Carsten Schmeel, Niklas Schaefer, Jennifer Landsberg, Michael Hoelzel, Ulrich Herrlinger, Matthias Schneider, Frank A. Giordano, Leonard Christopher Schmeel

Summary: This study evaluates the safety and outcome profile of five-fraction stereotactic radiotherapy (FSRT) for brain metastases (BM). It shows that FSRT is a feasible and efficient approach for both adjuvant and definitive treatment, with acceptable local control rates and comparable radiation necrosis rates.

CURRENT ONCOLOGY (2023)

No Data Available